SPX4,225.20+17.93 0.43%
DIA334.52+0.81 0.24%
IXIC12,856.21+76.30 0.60%

--Barclays Lowers Teladoc's Price Target to $40 From $42, Maintains Equalweight Rating

--Barclays Lowers Teladoc's Price Target to $40 From $42, Maintains Equalweight Rating

MT Newswires · 07/28/2022 05:48

Please log in to view news